# RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer

> **NCT04972448** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Breast Cancer
- Recurrence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04972448
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07
- **Primary completion:** 2025-05
- **Final completion:** 2025-11
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972448, "RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04972448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*